New Delhi, Feb. 7 -- Pharma stock Alkem Labs announced its results for the quarter ended December 2024 (Q3FY24) on Friday, February 7.

The company's consolidated net profit rose 6 percent year-on-year (YoY) to Rs.641 crore from Rs.604 crore in Q3FY24. Sequentially, profit fell almost 9 percent from 702 crore in the previous quarter (Q2FY25).

Total income for the quarter stood at Rs.3,467 crore, a marginal 1.4 percent increase from Rs.3,417.5 crore in the same period last year. On a quarter-on-quarter (QoQ) basis, revenue declined 2.3 percent from Rs.3,549 crore in Q2FY25.

For the nine months ending December 2024 (9MFY25), Alkem reported an over 25 percent YoY rise in net profit to Rs.1,893 crore, compared to Rs.1,507 crore in 9MFY24. T...